补肾养血方对卵巢早衰大鼠中抗苗勒氏管激素的影响  被引量:12

Effect of bushenyangxue prescription on the levels of anti-mullerian hormone in rat with premature ovarian failure

在线阅读下载全文

作  者:姬霞[1] 傅金英[1] 王冰玉[1] 胡俊攀 

机构地区:[1]河南省中医院,河南中医药大学第二附属医院妇产科,郑州450002

出  处:《中国比较医学杂志》2017年第1期49-53,共5页Chinese Journal of Comparative Medicine

基  金:河南省中医药管理局科研课题(2014ZY02013)

摘  要:目的建立雷公藤多苷致卵巢早衰大鼠的模型,研究补肾养血方对卵巢早衰大鼠中抗苗勒管素(anti-mullerian hormone,AMH)的影响。方法使用雷公藤多苷建立卵巢早衰大鼠模型,造模成功后,分别采用高,中,低剂量补肾养血方对大鼠灌胃,每日一次,共30 d。给药完毕后于显微镜下观察各组大鼠卵巢组织形态。酶联免疫吸附法、免疫组化染色法和定量反转录聚合酶连锁反应(qRT-PCR)分别检测大鼠血清中AMH含量以及卵巢内AMH的蛋白和mRNA表达水平。结果组织形态学显示高中低剂量组的卵泡和黄体的生长均比模型组好;酶联免疫吸附法、免疫组化和qRT-PCR结果显示补肾养血方呈剂量依赖性逆转雷公藤多苷导致大鼠血清中AMH浓度以及卵巢中AMH表达水平的降低。结论补肾养血方可逆转雷公藤多苷引起卵巢中AMH水平降低,提示补肾养血方具有防止卵巢早衰的功效。Objective Establish premature ovarian failure (POF) model in female Sprague Dawley by tripterygium wilfordii, and investigate the effect of bushenyangxue prescription on the levels of anti-mullerian hormone (AMH). Methods After POF model was established, rats were gave by gavage of different dosage of Bushenyangxue prescription for 30 days. The changes of histomorphology on rat ovarian tissue were observed by hematoxylin-eosin staining. Serum AMH concentraction, protein and mRNA expression of AMH were measure with ELISA, immunohistoehemical staining and qRT-PCR, respectively. Results The follicle and corpus luteum were atrophied after tripterygium wilfordii challenge, which was improved after treatment with Bushenyangxue prescription. Serum AMH, protein and mRNA expression of AMH were decreased tripterygium wilfordii-treated rats; this decrease was inhibited after treatment with Bushenyangxue prescription. Conclusions Our study indicates that Bushenyangxue prescription could preserve the AMH levels of POF rats. These findings suggest that Bushenyangxue prescription may be a useful strategy to treat POF.

关 键 词:补肾养血方 卵巢早衰 AMH 

分 类 号:R-332[医药卫生]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象